Allianz Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-13,700
| Closed | -$103K | – | 1548 |
|
2025
Q1 | $103K | Buy |
13,700
+1,200
| +10% | +$9K | ﹤0.01% | 1690 |
|
2024
Q4 | $94K | Buy |
+12,500
| New | +$94K | ﹤0.01% | 1656 |
|
2023
Q4 | – | Sell |
-33,300
| Closed | -$236K | – | 1615 |
|
2023
Q3 | $236K | Hold |
33,300
| – | – | ﹤0.01% | 1595 |
|
2023
Q2 | $234K | Buy |
33,300
+10,900
| +49% | +$76.7K | ﹤0.01% | 1418 |
|
2023
Q1 | $187K | Sell |
22,400
-23,900
| -52% | -$199K | ﹤0.01% | 1561 |
|
2022
Q4 | $532K | Sell |
46,300
-13,400
| -22% | -$154K | ﹤0.01% | 1351 |
|
2022
Q3 | $752K | Sell |
59,700
-385,975
| -87% | -$4.86M | ﹤0.01% | 1251 |
|
2022
Q2 | $4.72M | Buy |
445,675
+140,496
| +46% | +$1.49M | ﹤0.01% | 1060 |
|
2022
Q1 | $4.96M | Buy |
305,179
+42,064
| +16% | +$684K | ﹤0.01% | 1102 |
|
2021
Q4 | $3.64M | Buy |
263,115
+119,407
| +83% | +$1.65M | ﹤0.01% | 1212 |
|
2021
Q3 | $2.07M | Buy |
+143,708
| New | +$2.07M | ﹤0.01% | 1374 |
|
2020
Q3 | – | Sell |
-13,637
| Closed | -$65K | – | 1809 |
|
2020
Q2 | $65K | Buy |
+13,637
| New | +$65K | ﹤0.01% | 1851 |
|
2019
Q4 | – | Sell |
-107,890
| Closed | -$309K | – | 2228 |
|
2019
Q3 | $309K | Sell |
107,890
-157,254
| -59% | -$450K | ﹤0.01% | 2018 |
|
2019
Q2 | $1.01M | Sell |
265,144
-69,584
| -21% | -$264K | ﹤0.01% | 1748 |
|
2019
Q1 | $2.73M | Buy |
334,728
+65,325
| +24% | +$532K | ﹤0.01% | 1462 |
|
2018
Q4 | $2.17M | Sell |
269,403
-9,015
| -3% | -$72.7K | ﹤0.01% | 1449 |
|
2018
Q3 | $2.12M | Buy |
278,418
+48,005
| +21% | +$366K | ﹤0.01% | 1550 |
|
2018
Q2 | $1.32M | Sell |
230,413
-1,348
| -0.6% | -$7.72K | ﹤0.01% | 1653 |
|
2018
Q1 | $1.11M | Buy |
231,761
+66,783
| +40% | +$318K | ﹤0.01% | 1690 |
|
2017
Q4 | $810K | Buy |
164,978
+5,614
| +4% | +$27.6K | ﹤0.01% | 1786 |
|
2017
Q3 | $835K | Buy |
159,364
+41,727
| +35% | +$219K | ﹤0.01% | 1760 |
|
2017
Q2 | $654K | Sell |
117,637
-2,341
| -2% | -$13K | ﹤0.01% | 1817 |
|
2017
Q1 | $1.01M | Buy |
+119,978
| New | +$1.01M | ﹤0.01% | 1721 |
|
2015
Q4 | – | Sell |
-21,670
| Closed | -$247K | – | 1924 |
|
2015
Q3 | $247K | Buy |
+21,670
| New | +$247K | ﹤0.01% | 1785 |
|